Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-114697

See remarks sold 9,305 shares at an average $49.70 ($462,458)

  • See remarks acquired 9,305 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Goldshleger Ilya See remarks 2024-10-10 Option exercise 10b5-1 +3,105 $15.08 $46,823 45,351 D
Goldshleger Ilya See remarks 2024-10-10 Sale 10b5-1 −3,105 $48.82 $151,596 42,246 D
Goldshleger Ilya See remarks 2024-10-11 Option exercise 10b5-1 +3,100 $15.08 $46,748 45,346 D
Goldshleger Ilya See remarks 2024-10-11 Sale 10b5-1 −3,100 $50.19 $155,594 42,246 D
Goldshleger Ilya See remarks 2024-10-14 Option exercise 10b5-1 +3,100 $15.08 $46,748 45,346 D
Goldshleger Ilya See remarks 2024-10-14 Sale 10b5-1 −3,100 $50.09 $155,268 42,246 D
Derivatives
Goldshleger Ilya See remarks 2024-10-10 Option exercise · Stock Option (right to buy) 10b5-1 −3,105 90,397 D
Goldshleger Ilya See remarks 2024-10-11 Option exercise · Stock Option (right to buy) 10b5-1 −3,100 87,297 D
Goldshleger Ilya See remarks 2024-10-14 Option exercise · Stock Option (right to buy) 10b5-1 −3,100 84,197 D
Open-market sales · 9,305 sh · avg $49.70 · $462,458
Loading xslF345X05/ownership.xml…